Concerns About Methodology of a Trial Investigating Vaginal Health During Aromatase Inhibitor Therapy for Breast Cancer

JAMA Oncol. 2017 Aug 1;3(8):1140-1141. doi: 10.1001/jamaoncol.2017.2071.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aromatase
  • Aromatase Inhibitors
  • Breast Neoplasms*
  • Contraceptive Devices, Female*
  • Estradiol
  • Female
  • Humans
  • Libido
  • Testosterone

Substances

  • Aromatase Inhibitors
  • Testosterone
  • Estradiol
  • Aromatase